NutriBand (NTRB) Interest Expenses (2019 - 2026)
NutriBand's (NTRB) quarterly Interest Expenses came in at $5334.0 in Q1 2026, up 42.66% year-on-year from $3739.0 in Q1 2025, and down 3.86% quarter-over-quarter from $5548.0 in Q4 2025.
NutriBand (NTRB) Interest Expenses (2019 - 2026) Analysis & Trends
NutriBand has disclosed Interest Expenses across 8 years of filings, most recently posting $5334.0 for Q1 2026.
- Interest Expenses for Q1 2026 came in at $5334.0, up 42.66% year-over-year; the trailing twelve-month figure through Jan 2026 was $22535.0 (up 5.27% YoY), and the FY2026 annual result was $22535.0, up 5.27% from the prior year.
- Interest Expenses came in at $5334.0 for Q1 2026 at NutriBand, down from $5548.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $40200.0 in Q4 2023 to a low of -$109906.0 in Q1 2023.
- The 5-year median for Interest Expenses is $5334.0 (2026), against an average of $3167.8.
- Peak annual rise in Interest Expenses reached 913.62% in 2023, while the deepest fall reached 3585.76% in 2023.
- NutriBand's Interest Expenses stood at $3966.0 in 2022, then jumped by 913.62% to $40200.0 in 2023, then sank by 89.97% to $4031.0 in 2024, then soared by 37.63% to $5548.0 in 2025, then retreated by 3.86% to $5334.0 in 2026.
- The last three Interest Expenses figures came in at $5334.0 (Q1 2026), $5548.0 (Q4 2025), and $5773.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -5.58 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 5,334.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 5,334.00 |
| Jan 31, 2026 | 5,334.00 |
| Oct 31, 2025 | 5,548.00 |
| Oct 31, 2025 | 5,548.00 |
| Jul 31, 2025 | 5,773.00 |
| Jul 31, 2025 | 5,773.00 |
| Apr 30, 2025 | 5,880.00 |
| Apr 30, 2025 | 5,880.00 |
| Jan 31, 2025 | 3,739.00 |
| Jan 31, 2025 | 3,739.00 |
| Oct 31, 2024 | 4,031.00 |
| Oct 31, 2024 | 4,031.00 |
| Jul 31, 2024 | 5,019.00 |
| Jul 31, 2024 | 5,019.00 |
| Apr 30, 2024 | 8,618.00 |
| Apr 30, 2024 | 8,618.00 |
| Jan 31, 2024 | 23,214.00 |
| Jan 31, 2024 | 23,214.00 |
| Oct 31, 2023 | 40,200.00 |
| Oct 31, 2023 | 40,200.00 |